Skip to main content
Skip to main content
VFRM logo

Veritas Farms, Inc. (VFRM) Stock Analysis

$0.0001 +$0.00 (+0.00%) |CouncilBearish Lean · 23 · F
Veritas Farms, Inc. (VFRM) bottom line: signals are mixed — the Council read leans Bearish Lean (23/100) while the AI fundamental score is 0/100 (grade F); the two lenses disagree, so weigh the breakdown below. Strongest signal: Ray Dalio bullish · Biggest watch-out: Seth Klarman bearish.
Vol: 13.0K| 52-wk range: $0.0001 – $0.06005
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Veritas Farms, Inc. (VFRM) trades at $0.0001. Veritas Farms, Inc. specializes in the production, marketing, and distribution of hemp-derived phytocannabinoid products. Sector: Healthcare.

Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026
Veritas Farms, Inc. specializes in the production, marketing, and distribution of hemp-derived phytocannabinoid products. The company offers a range of products, including capsules, gummies, tinctures, and topicals, targeting both human and pet markets.

Analyst Coverage for VFRM: VFRM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VFRM against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the VFRM film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bearish Lean 23/100 · F

VFRM: 2/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Jim Simons
Neutral
Izzy Englander
Neutral
Seth Klarman
Bearish
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Negative
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Veritas Farms, Inc. (VFRM) Healthcare & Pipeline Overview

CEOThomas E. Vickers
Employees17
HeadquartersFort Lauderdale, US
IPO Year2017

Veritas Farms, Inc., operating in the specialty and generic drug manufacturing sector, focuses on hemp-derived phytocannabinoid products, marketing capsules, gummies, tinctures, and topicals under its brand and through private labels. The company faces challenges in a competitive market with negative profit and gross margins.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for VFRM?

As of Mar 16, 2026 — figures reflect the data available on that date.

Investing in Veritas Farms, Inc. presents a high-risk, high-reward scenario. The company's focus on the growing hemp-derived product market offers potential for revenue expansion, but its current financial metrics raise concerns. With a negative profit margin of -483.9% and a negative gross margin of -130.1%, the company needs to significantly improve its operational efficiency and cost management. Key value drivers include expanding its distribution network, developing innovative product formulations, and navigating the evolving regulatory landscape to its advantage. The company's small market capitalization makes it susceptible to volatility and market sentiment. Investors should closely monitor the company's ability to achieve profitability, manage its cash flow, and capitalize on the growth opportunities in the hemp-derived product market.

Based on FMP financials and quantitative analysis

VFRM Key Highlights

Market Cap of $0.00B indicates a micro-cap company with limited financial resources and higher volatility.

  • P/E Ratio of -0.00 reflects the company's current lack of profitability.
  • Profit Margin of -483.9% signals significant operational inefficiencies and high costs relative to revenue.
  • Gross Margin of -130.1% indicates that the cost of goods sold exceeds revenue, posing a substantial challenge to the company's financial viability.
  • Beta of 0.45 suggests the stock is less volatile than the overall market.

Who Are VFRM's Competitors?

VFRM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
INNPF INNOCAN PHARMA Corp $1.60 -8.05% $7.20M 61
GENH Generation Hemp, Inc. $0.22 +0.00% $25.3M 63
GBLP Global Pharmatech, Inc. $0.08 +0.00% $33.3M 62
ETST Earth Science Tech, Inc. $0.12 +14.45% $35.3M 61
GDNSF Goodness Growth Holdings, Inc. $0.45 +0.00% $61.1M 64
MNNGF Baijin Life Science Holdings Limited $0.08 +0.00% $74.6M 63
SHIEF Shield Therapeutics plc $0.07 +0.00% $75.3M 62
CNVCF BioHarvest Sciences Inc. $6.30 +0.00% $109M 66

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are VFRM's Key Strengths?

Established brand in the hemp-derived product market.

  • Diverse product line catering to various consumer needs.
  • White label and private label manufacturing capabilities.
  • Focus on natural health and wellness solutions.

What Are VFRM's Weaknesses?

Negative profit and gross margins.

  • Limited financial resources.
  • Small market capitalization.
  • Dependence on the evolving regulatory environment.

What Could Drive VFRM Stock Higher?

Potential changes in federal regulations regarding hemp-derived products could create new market opportunities.

  • Expansion of the company's distribution network through strategic partnerships.
  • Development and launch of new product formulations to meet evolving consumer demand.
  • Increasing consumer awareness and acceptance of hemp-derived products.
  • Potential for international market expansion in countries with favorable regulatory environments (2027-2028).

What Are the Key Risks for VFRM?

Financial-distress signal — its Altman Z-Score of -9.35 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Intense competition from established and emerging players in the hemp-derived product market.
  • Regulatory uncertainty and potential changes in legislation could negatively impact the company's operations.
  • Fluctuations in raw material prices could affect the company's profitability.
  • Negative publicity or consumer perception regarding hemp-derived products could harm the company's brand and sales.
  • The company's negative profit and gross margins pose a significant challenge to its financial viability.

What Are the Growth Opportunities for VFRM?

  • Expansion of Product Line: Veritas Farms can capitalize on the growing demand for diverse hemp-derived products by expanding its product line to include novel formulations and delivery methods. The market for cannabis-infused beverages, edibles, and cosmetic products is expanding rapidly, offering opportunities for Veritas Farms to capture new market segments. Successful product innovation and marketing could drive revenue growth and enhance brand recognition. Timeline: Ongoing.
  • Strategic Partnerships and Distribution Agreements: Forming strategic partnerships with established retailers and distributors can significantly expand Veritas Farms' market reach and access to new customer segments. Collaborations with national pharmacy chains, health food stores, and online retailers can provide access to a broader customer base and increase sales volume. Timeline: Ongoing.
  • White Label and Private Label Expansion: Veritas Farms can leverage its manufacturing capabilities to expand its white-label and private-label business, providing custom formulations for other brands and retailers. This strategy can generate a stable revenue stream and diversify the company's customer base. The market for private-label cannabis products is growing as retailers seek to offer unique and differentiated products. Timeline: Ongoing.
  • International Market Expansion: Exploring opportunities to expand into international markets with favorable regulatory environments for hemp-derived products can drive significant growth for Veritas Farms. Countries in Europe and Latin America are increasingly adopting more progressive cannabis policies, creating opportunities for market entry and expansion. Timeline: 2027-2028.
  • Focus on Pet Products: The market for hemp-derived pet products is experiencing rapid growth as pet owners seek natural solutions for their animals' health and wellness. Veritas Farms can capitalize on this trend by developing and marketing a comprehensive line of pet-specific products, including chews, tinctures, and topicals. Targeted marketing campaigns and partnerships with veterinary clinics and pet supply stores can drive sales and establish Veritas Farms as a leader in the pet CBD market. Timeline: Ongoing.

What Are VFRM's Competitive Advantages?

  • Brand recognition in the hemp-derived product market.
  • Proprietary formulations and manufacturing processes.
  • Established distribution network.
  • White label and private label capabilities providing diversified revenue streams.

What Does VFRM Do?

Veritas Farms, Inc., formerly known as SanSal Wellness Holdings, Inc., rebranded in February 2019 to concentrate on the burgeoning market for hemp-derived products. The company cultivates, manufactures, and distributes a diverse array of hemp oils and extracts containing phytocannabinoids. Its product line includes capsules, gummies, tinctures, lotions, salves, vape oils, creams, balm sticks, lip balms, and pet chews, catering to a broad consumer base seeking wellness solutions. Veritas Farms markets its products under its own brand name and also provides white-label and private-label custom formulations for distributors and retailers, expanding its market reach through strategic partnerships. Headquartered in Dania Beach, Florida, Veritas Farms aims to capitalize on the increasing consumer interest in natural health and wellness products derived from hemp. However, the company operates in a highly competitive and evolving regulatory landscape, which presents both opportunities and challenges for sustainable growth and market leadership.

What Products and Services Does VFRM Offer?

  • Produces hemp oils and extracts containing phytocannabinoids.
  • Manufactures capsules containing hemp-derived compounds.
  • Creates gummy products infused with phytocannabinoids.
  • Develops and sells tinctures for sublingual administration.
  • Formulates lotions and salves for topical application.
  • Produces vape oils containing hemp extracts.
  • Offers white label and private label custom formulations.

How Does VFRM Make Money?

  • Cultivates and processes hemp to extract phytocannabinoids.
  • Manufactures a range of hemp-derived products for human and pet consumption.
  • Markets and sells products under the Veritas Farms brand.
  • Provides white-label and private-label manufacturing services to other companies.

What Industry Does VFRM Operate In?

Veritas Farms, Inc. operates within the rapidly evolving market for hemp-derived products, a segment of the broader specialty and generic drug manufacturing industry. This market is characterized by increasing consumer demand for natural health and wellness solutions, but also faces regulatory uncertainty and intense competition. Companies in this space must navigate complex legal frameworks, establish strong branding, and differentiate themselves through product innovation and quality. The competitive landscape includes both established pharmaceutical companies exploring cannabis-based therapies and numerous smaller players focused on hemp-derived consumer products. The market is projected to experience significant growth, driven by increasing acceptance of cannabis and its derivatives for medicinal and recreational purposes.

Who Are VFRM's Key Customers?

  • Individual consumers seeking natural health and wellness products.
  • Retailers selling health and wellness products.
  • Distributors of hemp-derived products.
  • Other brands and retailers seeking private-label manufacturing services.
AI Confidence: 69% Updated: Mar 16, 2026

Key Financial Metrics

Return on assets is -75.7%, showing how much profit it generates from its asset base. A current ratio of 1.12 indicates the company holds enough short-term assets to cover its near-term obligations.

Company Profile

Veritas Farms, Inc. operates in the Chemicals industry within the Basic Materials sector. It is headquartered in Fort Lauderdale, US. The company is led by CEO Thomas E. Vickers. VFRM has traded publicly since 2017.

F-Score 3/9

Financial Health

Veritas Farms, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -9.35 places it in the distress zone, a signal of elevated financial risk.

VFRM Financials

Fundamental Snapshot

Return on Equity (TTM)
-243.8%
Current Ratio
1.1

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Established brand in the hemp-derived product market.
  • Diverse product line catering to various consumer needs.
  • White label and private label manufacturing capabilities.
  • Focus on natural health and wellness solutions.

Bear Case

  • Negative profit and gross margins.
  • Limited financial resources.
  • Small market capitalization.
  • Dependence on the evolving regulatory environment.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

VFRM Latest News

No recent news available for VFRM.

VFRM Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VFRM.

Price Targets

Wall Street price target analysis for VFRM.

VFRM MoonshotScore

0/100

What does this score mean?

The MoonshotScore rates VFRM 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Thomas E. Vickers

CEO

Thomas E. Vickers serves as the CEO of Veritas Farms, Inc. His background includes experience in managing and growing companies within the health and wellness sector. He has a track record of strategic leadership and operational expertise. Prior to joining Veritas Farms, Vickers held leadership positions in various companies, focusing on business development, marketing, and sales. His experience spans across different industries, providing him with a diverse skill set to lead Veritas Farms in a competitive market.

Track Record: Under Thomas E. Vickers' leadership, Veritas Farms, Inc. has focused on expanding its product line and distribution network. Key milestones include the rebranding of the company to Veritas Farms, Inc. and the development of new product formulations. Vickers has also overseen the company's efforts to navigate the evolving regulatory landscape and establish strategic partnerships. His focus has been on driving revenue growth and improving operational efficiency.

VFRM OTC Market Information

The OTC Other tier, also known as the Pink Sheets, represents the lowest tier of the over-the-counter (OTC) market. Unlike stocks listed on major exchanges like the NYSE or NASDAQ, companies on the OTC Other tier often have limited reporting requirements and may not meet minimum financial standards. This tier typically includes companies with limited operating history, distressed businesses, or those that choose not to comply with the stricter listing requirements of higher-tier exchanges. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight.

  • OTC Tier: OTC Other
Liquidity: Liquidity for VFRM shares on the OTC market is likely to be limited, potentially leading to wider bid-ask spreads and difficulties in buying or selling large volumes of shares without significantly impacting the price. The trading volume may be low, making it challenging to execute trades quickly and efficiently. Investors should be aware of the potential for price volatility and the risk of being unable to exit their positions at desired prices.
OTC Risk Factors:
  • Limited financial disclosure increases the risk of investing in VFRM.
  • Low trading volume can lead to price volatility and illiquidity.
  • The OTC Other tier has less regulatory oversight compared to major exchanges.
  • Potential for fraud or manipulation is higher on the OTC market.
  • The company may have difficulty raising capital due to its OTC listing.
Due Diligence Checklist:
  • Verify the company's legal status and registration.
  • Review the company's financial statements, if available.
  • Assess the company's management team and their experience.
  • Research the company's business model and competitive landscape.
  • Evaluate the company's compliance with regulatory requirements.
  • Check for any legal or regulatory issues.
  • Consult with a financial advisor before investing.
Legitimacy Signals:
  • The company has been in operation since 2019.
  • Veritas Farms has a range of hemp-derived products.
  • The company has a website and markets its products online.
  • The company has a CEO and management team.

What Investors Ask About Veritas Farms, Inc. (VFRM) — Healthcare

What does Veritas Farms, Inc. do?

Veritas Farms, Inc. is involved in the production, marketing, and distribution of hemp oils and extracts containing phytocannabinoids. The company offers a variety of products, including capsules, gummies, tinctures, lotions, salves, vape oils, creams, balm sticks, lip balms, and pet chews.

What do analysts say about VFRM stock?

As of March 16, 2026, there is no readily available analyst coverage or consensus on Veritas Farms, Inc. (VFRM) due to its OTC listing and small market capitalization. Investors should conduct their own thorough research and due diligence before considering an investment in VFRM.

What are the main risks for VFRM?

Veritas Farms, Inc. faces several key risks, including intense competition in the hemp-derived product market, regulatory uncertainty, fluctuations in raw material prices, and potential negative publicity. The company's negative profit and gross margins pose a significant challenge to its financial viability.

What are the key factors to evaluate for VFRM?

Evaluate VFRM on fundamentals, analyst consensus, and risk factors. Investing in Veritas Farms, Inc. presents a high-risk, high-reward scenario. Not financial advice.

How frequently does VFRM data refresh on this page?

VFRM's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven VFRM's recent stock price performance?

Veritas Farms, Inc. (VFRM) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand in the hemp-derived product market. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider VFRM overvalued or undervalued right now?

Veritas Farms, Inc. (VFRM) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research VFRM before investing?

Before investing in Veritas Farms, Inc. (VFRM), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recently available information.
  • OTC market data may be limited and less reliable than data from major exchanges.
  • AI analysis is pending and may provide additional insights in the future.
Data Sources

Popular Stocks

More Stocks We Cover